Ticker

ENGN

enGene Holdings Inc.

6 catalysts on file

ENGN

enGene Holdings Inc.

PDUFA AI-extracted

detalimogene voraplasmid

high-risk, non-muscle invasive bladder cancer (NMIBC)

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 13h ago

Countdown card →

ENGN

enGene Holdings Inc.

Phase 2 AI-extracted

detalimogene voraplasmid

high-risk, non-muscle invasive bladder cancer (NMIBC)

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 13h ago

Countdown card →

ENGN

enGene Therapeutics Inc.

Catalyst AI-extracted

detalimogene

T-minus 450 days ~ Sep 30, 2027

SEC 8-K verified 13h ago

Countdown card →

ENGN

enGene Therapeutics Inc.

Approval AI-extracted

detalimogene

T-minus 908 days ~ Dec 31, 2028

SEC 8-K verified 13h ago

Countdown card →

ENGN

enGene Holdings Inc.

Approval AI-extracted

detalimogene voraplasmid

high-risk, non-muscle invasive bladder cancer (NMIBC)

Date TBD Date TBD

SEC 8-K verified 13h ago

Countdown card →

ENGN

enGene Holdings Inc.

CRL AI-extracted

detalimogene voraplasmid

high-risk, non-muscle invasive bladder cancer (NMIBC)

Date TBD Date TBD

SEC 8-K verified 13h ago

Countdown card →